12/2014. Clustoid Study

It has been published in the journal Allergy a clinical trial, randomized double-blind, placebo-controlled study, performed in Germany with CLUSTOID.

Title: A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol”

Authors: Klimek L, Uhlig J, Mösges R, Rettig K, Pfaar O.

Center for Rhinology and Allergology, Wiesbaden; Germany

Roxall Medizin, Hamburg; Germany

IMSIE, University of Cologne, Cologne; Germany

GEM, Bureau of Evaluation & Quality Assurance in Medicine GmbH, Meerbusch, Germany


CLUSTOID is an allergy vaccine containing glutaraldehyde-polymerized allergens. CLUSTOID is manufactured by INMUNOTEK and marketed in Germany by Roxall Medizin GmbH. In other countries is also marketed as CLUSTOID (Spain, Austria and Italy), or as CLUSTEK/ALXOID.

This is the second paper on the clinical efficacy of CLUSTOID. See the first one

Download the paper

12/2014. Estudio CLUSTOID